Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291564 · ClinicalTrials.gov registry record
Ensure Cardiac Resynchronization Therapy Study
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 430
- Enrollment target
NCT00291564: Completed study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
NCT00291564 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 430 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00291564 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 430 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate the therapy approach for converting abnormally fast heartbeats into normal heartbeats. There are no experimental devices or procedures involved in this study.
Interventions
- DEVICE Cardiac Resynchronization Therapy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2004-05 |
| Est. Completion | 2006-02 |
What the finished NCT00291564 record still lists
NCT00291564 is an observational study that tracks outcomes without assigning an intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Resynchronization Therapy Device is the first listed.
NCT00291564 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00291564 about?
NCT00291564 is a clinical study titled "Ensure Cardiac Resynchronization Therapy Study". The purpose of this study is to gather information on how doctors program particular settings on cardiac resynchronization therapy implantable cardiac defibrillators (CRT-Ds), to analyze how these settings affect the amount of cardiac resynchronization therapy (CRT) patients receive and to evaluate ...
What is the current status of trial NCT00291564?
This trial is currently completed. The enrollment target is 430 participants. The study started on 2004-05. Estimated completion is 2006-02.
What interventions are being tested in trial NCT00291564?
The interventions under investigation include: Cardiac Resynchronization Therapy Device (DEVICE).
Who is sponsoring clinical trial NCT00291564?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05327023 · 430 participants · Phase 1
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
- NCT05457985 · 430 participants · NA
Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers
- NCT05532982 · 430 participants
Parkinson's Disease in Asian Americans
- NCT05844891 · 430 participants · NA
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia